Malignant pleural mesothelioma survival rate

Malignant pleural mesothelioma is the most common form of malignant mesothelioma. Many factors can determine the survival rate for this aggressive form of cancer be involved in the, some are better understood than others. The estimates of median survival time ranging from one to two years, depends on underlying factors such as the nature and extent of the spread of mesothelioma. That only seven percent of people with this cancer for five years after diagnosis, survival survive, butOutlook is gradually improving with some promising experimental treatments. Some people live beyond five years from the time of diagnosis.

In general, younger age at diagnosis, no weight loss and associated loss of lung function with limited opportunities for increased survival. Stage I mesothelioma, which have not spread to the lymph nodes or adjacent tissues and organs carry the best prognosis. The type of the cancer cell is made up may also affect survival. The epithelioid cell type has the best prognosis, the mixed or biphasic cell type, the next best prognosis, and the sarcomatoid cell type the worst prognosis. The majority of malignant pleural mesothelioma are epithelioid cell type.

Since this cancer takes so long to manifest disease, people are usually diagnosed at an older age and with advanced, potentially worsening the prognosis and treatment options. The more aggressive the> Treatment, the better the outcome may be, but in cases with cancer, the body has spread to other parts, chemotherapy may be the only alternative. New drugs, such as the combination of Alimta with Platinol, have to show that chemotherapy, the survival rate for malignant mesothelioma patients whose only option. A number of experimental treatments such as immunotherapy and biotherapy, are currently being evaluated in clinical studies.

Thanks To : cheap canon digital camera